Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D)... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GUTS is expected to report earnings to rise 300.00% to -23 cents per share on November 18
Q3'26
Est.
$-0.24
Q1'26
Beat
by $0.19
Q4'25
Beat
by $0.10
Q3'25
Missed
by $0.29
Q2'25
Missed
by $0.13
The last earnings report on May 12 showed earnings per share of -5 cents, beating the estimate of -25 cents. With 2.30M shares outstanding, the current market capitalization sits at 124.16M.